FMA
IMGN

FNY Managed Accounts’s Immunogen Inc IMGN Stock Holding History

FNY Managed Accounts’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$6K Buy
630
+230
+58% +$2.27K 0.01% 222
2017
Q4 		$2K Sell
400
-2,000
-83% -$12.3K ﹤0.01% 529
2017
Q3 		$18K Buy
+2,400
New +$15.9K 0.02% 363

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Managed Accounts's IMGN Position: Q1 2018 in Review

FNY Managed Accounts increased its Immunogen Inc (IMGN) stake by 58% in Q1 2018, buying an estimated $2.27K and bringing the position to 630 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #222.

FNY Managed Accounts first reported a position in IMGN in Q3 2017 and has held it in 3 quarters since. The position peaked at $18K in Q3 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q1 2018.

  • FNY Managed Accounts held 630 shares of Immunogen Inc worth $6K as of Q1 2018.
  • FNY Managed Accounts bought 230 Immunogen Inc shares in Q1 2018, an estimated $2.27K.
  • Immunogen Inc made up 0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #222 holding.
  • FNY Managed Accounts first reported a position in Immunogen Inc in Q3 2017 and has held it in 3 quarters since.
  • FNY Managed Accounts's Immunogen Inc position peaked at $18K in Q3 2017.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.